OMC
GENE

Old Mission Capital’s Genetic Technologies Ltd. GENE Stock Holding History

Old Mission Capital’s Portfolio GENE Stock Details GENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-4,322
Closed -$25.1K – 1579
2023
Q1 		$25.1K Sell
4,322
-9,726
-69% -$56.9K ﹤0.01% 1372
2022
Q4 		$65.3K Buy
14,048
+7,348
+110% +$41.7K ﹤0.01% 1154
2022
Q3 		$39K Buy
+6,700
New +$48.9K ﹤0.01% 871
2019
Q3 		– Sell
-851
Closed -$10K – 354
2019
Q2 		$10K Buy
+851
New +$13.1K ﹤0.01% 259

Other funds holding GENE

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
SA
Scarborough Advisors Annapolis, Maryland $871M AUM 21.96% 1-Year Est. Return
GI
Gradient Investments Arden Hills, Minnesota $7.25B AUM 20.71% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
NC
NewSquare Capital Newtown Square, Pennsylvania $1.15B AUM 24.78% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Old Mission Capital's GENE Position: Q2 2023 in Review

Old Mission Capital sold out of Genetic Technologies Ltd. (GENE) in Q2 2023, closing a stake of 4,322 shares — an estimated $25.1K sold.

Old Mission Capital first reported a position in GENE in Q2 2019 and held it in 4 quarters. The position peaked at $65.3K in Q4 2022. 11 funds tracked by Wall St. Rank hold GENE as of Q2 2023.

  • Old Mission Capital reported no remaining Genetic Technologies Ltd. position as of Q2 2023 after selling out during the quarter.
  • Old Mission Capital sold 4,322 Genetic Technologies Ltd. shares in Q2 2023, an estimated $25.1K.
  • Old Mission Capital first reported a position in Genetic Technologies Ltd. in Q2 2019 and held it in 4 quarters.
  • Old Mission Capital's Genetic Technologies Ltd. position peaked at $65.3K in Q4 2022.
  • 11 funds tracked by Wall St. Rank held Genetic Technologies Ltd. as of Q2 2023.

Based on Old Mission Capital's 13F filing for Q2 2023, filed 9 Aug 2023.